Watson Receives FDA Final Approval for Generic Wellbutrin XL(R) 300 Mg
U.S. Newswire, June, 2007
To: BUSINESS EDITORS
Contact: Patty Eisenhaur of Watson Pharmaceuticals, Inc., +1-951- 493-5611
CORONA, Calif., June 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced that it has received final approval from the United States (U.S.) Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for bupropion hydrochloride extended- release tablets, 300 mg. Bupropion hydrochloride extended-release is the generic equivalent to GlaxoSmithKline's Wellbutrin XL(R) tablets, which is indicated for the treatment of ...
Most Recent Business Articles
- How do I determine my retainer fee?
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- The CLNC® mentors held the key to my first case and to my CLNC® success
- Atlanta CLNC® 6-day certification seminar photo gallery—plus sign up today for spring 2009 to save $100.00
- Speak to a full-time practicing CLNC® consultant
Most Recent Business Publications
Most Popular Business Articles
- Using object-oriented analysis and design over traditional structured analysis and design
- Big Fish Games Migrates Upstream to Fisher Plaza; High Growth Online Gaming Firm Vaults Fisher Plaza Occupancy Rate Above 90%
- Top of the line: some of the world's most well-respected doctors practice in South Florida. A guide to choosing the best physician specialists - Top Doctors in South Florida
- Sand filter basics: high-rate sand filters can be confusing for those new to the business. Understanding valve modes is the key
- BEHR Paints Introduces a Colorful New Way to Paint and Prime All in One with BEHR Premium Plus Ultra™ Interior
Sponsored by Merrill Lynch